Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39.8Revenue $M0.2Net Margin (%)-3,184.4Z-Score4.2
Enterprise Value $M15.4EPS $-2.4Operating Margin %-3,295.6F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-3,251.9Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %-37.1Quick Ratio24.6Cash flow > EarningsY
Price/Sales95.05-y EBITDA Growth Rate %-65.7Current Ratio25.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-49.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M9.7ROI % (ttm)-70.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 54.

No Entry found!

ROSG is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

    Quarterly/Annual Reports about ROSG:

      News about ROSG:

      Articles On GuruFocus.com
      Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update Sep 08 2009 
      Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd. Jan 08 2009 
      Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Hide